ATE505561T1 - GENE AND POLYPEPTIDE RELATED TO BREAST CANCER - Google Patents

GENE AND POLYPEPTIDE RELATED TO BREAST CANCER

Info

Publication number
ATE505561T1
ATE505561T1 AT06782210T AT06782210T ATE505561T1 AT E505561 T1 ATE505561 T1 AT E505561T1 AT 06782210 T AT06782210 T AT 06782210T AT 06782210 T AT06782210 T AT 06782210T AT E505561 T1 ATE505561 T1 AT E505561T1
Authority
AT
Austria
Prior art keywords
gene
breast cancer
polypeptide related
polypeptide
breast
Prior art date
Application number
AT06782210T
Other languages
German (de)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Shuichi Nakatsuru
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of ATE505561T1 publication Critical patent/ATE505561T1/en

Links

AT06782210T 2005-07-29 2006-07-26 GENE AND POLYPEPTIDE RELATED TO BREAST CANCER ATE505561T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70365805P 2005-07-29 2005-07-29
JP2006015341 2006-07-26

Publications (1)

Publication Number Publication Date
ATE505561T1 true ATE505561T1 (en) 2011-04-15

Family

ID=43825189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06782210T ATE505561T1 (en) 2005-07-29 2006-07-26 GENE AND POLYPEPTIDE RELATED TO BREAST CANCER

Country Status (1)

Country Link
AT (1) ATE505561T1 (en)

Similar Documents

Publication Publication Date Title
PL2567707T3 (en) Composition of tumor associated peptides and related vaccine against cancer
HRP20130720T1 (en) Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
ATE538137T1 (en) ANTIBODIES TO HUMAN IL-22 AND USES THEREOF
GB2429207A9 (en) Modified human interferon polypeptides and their uses
ES2869167T8 (en) PIK3CA gene mutations in human cancers
BRPI1004572A2 (en) "Recurrent genetic fusions in cancer
PL2601961T3 (en) Compositions comprising LAG-3 and therapeutic antibodies and their uses in the treatment of cancer
DK2068909T3 (en) Modified FGF-21 polypeptides and their use
IL202213A0 (en) Recombinant protein production in avian ebxr cells
EP2038041A4 (en) Therapeutic compounds and their use in cancer
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
IL191999A0 (en) Targeting gli proteins in human cancer by small molecules
ZA200901680B (en) Recombinant human interferon-like proteins
DK2396659T3 (en) RBM3 protein in testicular cancer diagnosis and prognosis
DK3401327T3 (en) GENERAL PRODUCTS WITH DIFFERENT EXPRESSION IN TUMORS AND USES THEREOF
IL236869A (en) Puro-dhfr marker and its use in protein production
LT2139917T (en) Anti-androgen peptides and uses thereof in cancer therapy
DE602006021315D1 (en) GENE AND POLYPEPTIDE IN CONNECTION WITH BREAST CANCER
ZA200606216B (en) Modified human interferon polypeptides and their uses
ATE505561T1 (en) GENE AND POLYPEPTIDE RELATED TO BREAST CANCER
DE602006020451D1 (en) GENES AND POLYPEPTIDES RELATED TO PROSTATE CANCER
EP1922328A4 (en) Peptides targeted to protein kinase c isoforms and uses thereof
ZA200802541B (en) Human antibodies against IL13 and therapeutic uses
ITMI20052327A1 (en) MODIFIED RECOMBINANT HUMAN LISOZYME
ATE500511T1 (en) GENES AND POLYPEPTIDES RELATED TO PROSTATE CANCER

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties